What Is Melanotan 2 Used For in Research?
Melanotan 2 (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH) widely evaluated in preclinical research models. Principal laboratory investigations focus on its non-selective melanocortin receptor agonism, melanogenesis pathways, and systemic physiological responses in cellular and animal models. PX1 Research supplies high-purity MT-II exclusively for qualified laboratory and in vitro evaluation.
Quick answer
Melanotan 2 (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH) widely evaluated in preclinical research models. Principal laboratory investigations focus on its non-selective melanocortin receptor agonism, melanogenesis pathways, and systemic physiological responses in cellular and animal models. PX1 Research supplies high-purity MT-II exclusively for qualified laboratory and in vitro evaluation.
Key takeaways
- What is [Melanotan](/research-peptides/melanotan-2) 2 used for in modern biomedical research?
- [Melanotan](/research-peptides/melanotan-2) 2 is a synthetic analog with the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2.
- In dermatological and cell biology research, MT-II is extensively deployed to study melanogenesis—the enzymatic cascade responsible for melanin synthesis in melanocytes.
- Beyond localized melanocyte pathways, preclinical rodent models utilize [Melanotan](/research-peptides/melanotan-2) 2 to probe central melanocortin system functionality.
Preclinical Applications of Melanotan 2: Executive Summary
What is Melanotan 2 used for in modern biomedical research? In laboratory settings, Melanotan 2 (MT-II) is utilized primarily as a non-selective melanocortin receptor agonist to investigate melanocortin receptor kinetics, melanogenesis signaling cascades, energy homeostasis pathways, and central nervous system signaling mechanisms. Preclinical studies suggest that its cyclic lactam structure confers significantly higher metabolic stability and receptor binding affinity compared to endogenous alpha-melanocyte-stimulating hormone (α-MSH).
Researchers examine high-purity compounds like MT-II 10mg in controlled experimental environments to map signal transduction across melanocortin receptor subtypes (MC1R through MC5R). Because MT-II lacks subtype selectivity, it serves as a robust tool compound for profiling competitive binding, receptor dimerization, and downstream second-messenger cascades such as cyclic adenosine monophosphate (cAMP) accumulation.
Molecular Structure and Melanocortin Receptor Kinetics
Melanotan 2 is a synthetic analog with the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. The introduction of a cyclic lactam bridge between the Asp and Lys residues, combined with the substitution of D-phenylalanine for L-phenylalanine, imparts structural rigidity. In vitro binding assays demonstrate that this conformation resists rapid enzymatic degradation by serine proteases and peptidases, allowing for sustained receptor engagement in culture assays.
Pharmacological profiling reveals that Melanotan 2 binds to multiple melanocortin receptors with varying sub-nanomolar to low-nanomolar affinities. It functions as a potent full agonist at MC1R, MC3R, MC4R, and MC5R. In cell-based reporter assays, binding to MC1R activates Gs-protein-coupled signaling, which stimulates adenylyl cyclase activity and increases intracellular cAMP levels. Understanding these binding dynamics across receptor sub-types allows investigators to map receptor-mediated pathways across diverse biological targets in our comprehensive catalog of research peptides.
In Vitro Research Applications: Melanogenesis and Pigmentation Pathways
In dermatological and cell biology research, MT-II is extensively deployed to study melanogenesis—the enzymatic cascade responsible for melanin synthesis in melanocytes. Preclinical cell culture models utilizing murine B16-F10 melanoma cells or human primary epidermal melanocytes demonstrate that MT-II activation of MC1R leads to up-regulation of microphthalmia-associated transcription factor (MITF).
Elevated MITF transcription subsequently induces the expression of key melanogenic enzymes, including tyrosinase, tyrosinase-related protein 1 (TRP-1), and tyrosinase-related protein 2 (TRP-2). Laboratory endpoints in these in vitro assays typically quantify tyrosinase activity via L-DOPA oxidation rate assays, intracellular melanin content using spectrophotometric absorbance at 475 nm, and gene expression profiling via quantitative real-time PCR (qPCR).
In Vivo Rodent Models: Central and Peripheral Signaling Endpoints
Beyond localized melanocyte pathways, preclinical rodent models utilize Melanotan 2 to probe central melanocortin system functionality. The central nervous system, particularly the arcuate nucleus and paraventricular nucleus of the hypothalamus, expresses high densities of MC3R and MC4R. When administered in animal models via intracerebroventricular (ICV) or systemic routes, MT-II provides insight into satiety signaling, energy expenditure, and metabolic homeostasis.
Researchers measure specific physiological and behavioral endpoints in rodent subjects, including changes in acute food intake, oxygen consumption via indirect calorimetry, core body temperature modulation, and neuroendocrine axis responses. Additionally, because MC4R activation influences autonomic pathways, studies frequently record mean arterial pressure (MAP) and heart rate parameters to characterize the cardiovascular impact of systemic melanocortin agonism.
Comparative Analysis: Melanotan 2 vs. Related Melanocortin Peptides
To understand the unique pharmacological profile of MT-II, comparative studies frequently evaluate it alongside related melanocortin analogs within the same research class. Distinctions in structural conformation, subtype selectivity, and metabolic stability dictate their specific utility across different experimental paradigms.
While MT-II contains a cyclic lactam bridge that activates MC1R, MC3R, MC4R, and MC5R, linear analogs like Melanotan 1 (Afamelanotide) display higher relative selectivity for MC1R over central receptor subtypes. Conversely, selective compounds such as Bremelanotide PT-141—a metabolite structure derived from MT-II—are specifically utilized in studies targeting MC3R and MC4R central pathways without primary emphasis on MC1R-driven melanogenesis. Comparative binding studies assist researchers in isolating the precise receptor subtypes responsible for downstream physiological endpoints.
Analytical Assay Methods for Quantifying Melanotan 2 Activity
Laboratories investigating MT-II employ a suite of validated analytical techniques to assess biological potency, binding parameters, and structural stability in vitro. Standard experimental workflows include:
1. **cAMP Accumulation Assays:** Utilizing homogeneous time-resolved fluorescence (HTRF) or enzyme-linked immunosorbent assays (ELISA) to measure Gs activation post-receptor stimulation. 2. **Radioligand Binding Studies:** Employing [125I]-labeled α-MSH competition assays to calculate displacement constants (Ki) and receptor density (Bmax). 3. **Western Blotting and Protein Quantitation:** Assessing phosphorylation state changes in ERK1/2 and CREB downstream of melanocortin activation. 4. **High-Performance Liquid Chromatography (HPLC):** Monitoring chemical stability, degradation kinetics, and peptide recovery across various buffer compositions and pH levels.
Laboratory Reconstitution and Handling Parameters
Proper preparation and storage are vital for maintaining the structural integrity of MT-II during long-term experimental protocols. Lyophilized MT-II trifluoroacetate salt should be stored at -20°C or -80°C in a desiccated environment to prevent moisture uptake and hydrolysis.
Reconstitution should be performed using sterile Bacteriostatic Water or phosphate-buffered saline (PBS, pH 7.4) under a laminar flow hood. To ensure accurate concentration calculations for in vitro assays or micro-injection volumes, researchers should consult the PX1 Reconstitution Calculator. Reconstituted stock solutions should be aliquoted into low-protein-binding microcentrifuge tubes to prevent adsorption loss and avoid repeated freeze-thaw cycles.
Quality Standards and Verification for Research-Grade MT-II
Experimental reproducibility depends entirely on the chemical purity and batch-to-batch consistency of the target compound. PX1 Research enforces strict quality control standards for all analytical compounds. Every lot of MT-II undergoes rigorous analytical testing in ISO 17025 accredited laboratories.
We provide detailed documentation including a lot-specific Certificate of Analysis (COA), verifying compound identity via Mass Spectrometry (MS) and chemical purity (exceeding 99%) via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). Furthermore, all samples undergo chromogenic LAL assays to ensure endotoxin levels remain strictly below regulatory thresholds for cellular and preclinical models. Institutional laboratories seeking bulk quantities for multi-stage protocols can explore our wholesale account program.
Frequently Asked Questions
What is Melanotan 2 used for in laboratory research?
Melanotan 2 is primarily used in preclinical research to investigate melanocortin receptor signaling dynamics (MC1R–MC5R), melanogenesis pathways in melanocytes, central satiety cascades, and structural interactions of cyclic peptides.
What receptor sub-types does Melanotan 2 target?
MT-II acts as a non-selective agonist across the melanocortin receptor family, demonstrating high binding affinity at MC1R, MC3R, MC4R, and MC5R.
How does Melanotan 2 differ structurally from native alpha-MSH?
Unlike native linear α-MSH, Melanotan 2 features a cyclic lactam structure (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2). This structural modification significantly enhances enzymatic resistance and receptor affinity.
How is MT-II purity verified at PX1 Research?
PX1 Research verifies every batch of MT-II using RP-HPLC for purity (>99%) and Mass Spectrometry for structural identity. Analytical documentation is available on our dedicated Certificate of Analysis page.
What solvent is recommended for reconstituting Melanotan 2 for laboratory assays?
For standard laboratory research protocols, lyophilized MT-II is typically reconstituted using sterile Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4).
Are PX1 Research compounds intended for human use?
No. All products supplied by PX1 Research are strictly intended for laboratory research, in vitro experimentation, and preclinical animal models. They are not for human, clinical, or veterinary use.
What is the endotoxin threshold for PX1 Research peptides?
PX1 Research peptides undergo bacterial endotoxin testing via chromogenic LAL assays to ensure levels meet stringent laboratory safety standards (<0.01 EU/μg) for sensitive cell culture and animal studies.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.